http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3620453-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ea17ba87480b776cce77451f86b25bb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-233
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-233
filingDate 2018-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e55214085d7b15776fe6088914ffdaec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1030e47be99f94e4348e630cc0c0b64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4018d54868b6f70d0bacff8f8b2a2864
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f7b794a8727601d14cd2a1613932da4
publicationDate 2020-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3620453-A1
titleOfInvention New crystal form of lenvatinib
abstract The present invention provides a novel crystalline form of Lenvatinib mesylate, 4-[3-Chloro-4-(N'-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide methanesulfonate, a process for its preparation, AND pharmaceutical compositions comprising the novel polymorphic form of Lenvatinib mesylate as active ingredient, in admixture with pharmaceutical excipients.
priorityDate 2018-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007078159-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018054792-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1894918-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106551911-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11237762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227135070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449523792
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498072
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9823820

Total number of triples: 25.